Compare DSL & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DSL | PAHC |
|---|---|---|
| Founded | 2013 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 2013 | 2014 |
| Metric | DSL | PAHC |
|---|---|---|
| Price | $9.68 | $39.09 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $47.00 |
| AVG Volume (30 Days) | ★ 840.0K | 202.3K |
| Earning Date | 01-01-0001 | 11-09-2026 |
| Dividend Yield | ★ 13.50% | 1.24% |
| EPS Growth | N/A | ★ 104.20 |
| EPS | N/A | ★ 2.43 |
| Revenue | N/A | ★ $833,350,000.00 |
| Revenue This Year | N/A | $3.91 |
| Revenue Next Year | N/A | $3.48 |
| P/E Ratio | ★ N/A | $15.97 |
| Revenue Growth | N/A | ★ 4.12 |
| 52 Week Low | $9.64 | $28.25 |
| 52 Week High | $11.83 | $60.08 |
| Indicator | DSL | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 34.59 | 59.60 |
| Support Level | $9.64 | $38.29 |
| Resistance Level | $11.04 | $40.65 |
| Average True Range (ATR) | 0.13 | 1.41 |
| MACD | 0.01 | 0.13 |
| Stochastic Oscillator | 12.00 | 64.26 |
DoubleLine Income Solutions Fund is a closed-end management investment company. Its primary investment objective is to seek high income and its secondary objective is to seek capital appreciation. It invests in debt securities and other income-producing investments anywhere in the world, including emerging markets. The company's investment portfolio comprises foreign corporate bonds, U.S. corporate bonds, bank loans, collateralized loan obligations, non-agency commercial mortgage backed obligations, asset-backed obligations, and municipal bonds among others.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.